Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Bristol-Myers Squibb (BMS) building

BMS closer to kidney cancer approval for Opdivo

Wins priority review for renal cell carcinoma

- PMLiVE

Merck seeks oasis in CETP inhibitor desert

Pledgesto continue anacetrapib trials despite series of failures in its class

CAR-T cancer therapy passes milestone

Belgianbiotech Celyad's cancer immunotherapy will now be tested at higher doses

- PMLiVE

Mylan misses Perrigo takeover deadline

Failureto take 50% stake ends near-term hopes for a bid

- PMLiVE

J&J gets FDA green light for myeloma drug Darzalex

First-in-classtargeted immunotherapy wins US approval

Boehringer Ingelheim headquarters

Boehringer pledges €11bn to fund R&D drive

Plans more external collaborations as it appears to reduce spending

- PMLiVE

Astellas sells dermatology unit to Leo for €675m

Continuesthe company's restructuring drive

Making a difference to patients with IBD

Changing lives with medical education

Lucid Group Communications Limited

- PMLiVE

Astellas appoints Peter Sandor as head of oncology

He joins the company from Amgen

- PMLiVE

AZ’s Mene Pangalos joins Precision Medicine Catapult board

Has also been appointed a fellow at the University of Cambridge

Roche Basel Switzerland

Roche exits four manufacturing sites with loss of 1,200 jobs

Closes three Europeans plants and one US facility

- PMLiVE

J&J and Hanmi collaborate on diabetes and obesity

Alliance worth up to$915m

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links